IRadimed Corporation (IRMD) is a Medical - Devices company in the Healthcare sector, currently trading at $93.56. It has a SharesGrow Score of 79/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of IRMD = $64.16 (-31.4% from the current price, the stock appears overvalued). Analyst consensus target is IRMD = $120 (+28.3% upside).
Valuation: IRMD trades at a trailing Price-to-Earnings (P/E) of 55 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.83.
Financials: revenue is $84M, +16.4%/yr average growth. Net income is $22M, growing at +20.9%/yr. Net profit margin is 26.8% (strong). Gross margin is 76.7% (-0.7 pp trend).
Balance sheet: total debt is $0 against $95M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 7.98 (strong liquidity). Debt-to-assets is 0%. Total assets: $109M.
Analyst outlook: 2 / 2 analysts rate IRMD as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 27/100 (Fail), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 58/100 (Partial), Future 94/100 (Pass), Income 85/100 (Pass).
